MRK vs XAIR · P/E 33, rev $16.61B vs rev $7.7M
Merck & Company Inc (MRK) versus Beyond Air Inc (XAIR) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Beyond Air Inc (XAIR) is a medical devices company listed on US.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported XAIR revenue for 2026-03-31 was $7.7M. Net income was -$33.2M. Revenue was up 107.3% from 2025-03-31 to 2026-03-31. XAIR currently screens at market cap $16.0M.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. XAIR currently screens at market cap $16.0M.
Not investment advice. Open the MRK and XAIR stock pages for the full models.
Not investment advice.